Event Notification Report for September 29, 2026

AGREEMENT STATE REPORT - CONTAMINATED PACKAGE

The following is a summary of information provided by the Ohio Department of Health, Bureau of Environmental Health and Radiation Protection (the Department), via email:

On September 21, 2026, Kettering Health Network notified the Department by email that a radiopharmaceutical package containing 10 mCi of F-18 positron emission tomography (PET) material exceeded removable contamination limits established in Ohio Administrative Code 3701:1-38-18, which references limits in 49 CFR 173.443.

The event occurred on September 17, 2026. Contamination on the exterior case was 10,197 disintegrations per minute (dpm), the syringe pig was 2,303 dpm, and the syringe body was 4,848 dpm. The exposure rate on contact was 0.8 mR/h and at one meter was 0.1 mR/h. The licensee implemented appropriate handling precautions and stored the package for decay, which decayed below regulatory limits by end of day. The licensee attempted to contact the radiopharmacy on the same day as the event but could not make contact until the next day.

The radiation safety officer (RSO) was notified by phone on the day of the event. A written report was provided to the RSO on September 18, 2026, but the RSO was out of office. The licensee was reminded that they must notify the Department immediately when a package survey exceeds regulatory limits.

The radiopharmacy responsible, PETNET, is due for their routine inspection. This inspection will be prioritized, and the incident will be reviewed again during the routine inspection.

Ohio item number: OH260007

AGREEMENT STATE REPORT - RECOVERED SOURCE

The following is a summary of information that was provided by the North Carolina Department of Health and Human Services Radioactive Materials Branch (RMB) via email:

RMB reports that an electron capture device (ECD) was found undamaged in a scrap yard. The ECD was identified as belonging to Proctor and Gamble, a generally licensed entity in North Carolina. The ECD was returned to Proctor and Gamble and RMB's investigation is currently ongoing.

Corrective actions include the licensee conducting inventory reviews to account for all sources.

Device: Filtec model FT-50 (S/N: 40568)
Source: 100 mCi of Am-241

NC event number: NC260016
NMED number: 260342

AGREEMENT STATE REPORT - DOSE TO EMBRYO

The following information was received from the New York State Department of Health (NYSDOH), Bureau of Environmental Radiation Protection via email:

"On September 22, 2026 at 1300 EDT, NYSDOH was notified of a possible reportable event under 10 CFR 35.3047.

"A female patient was treated for hyperthyroidism (29.5 mCi of I-131) on August 19, 2026. In accordance with standard clinical protocols, the patient was tested for potential pregnancy as part of the patient selection process for these procedures. This test returned `negative' and the treatment was authorized in accordance with standard procedures and protocols.

"The patient contacted the licensee this morning to notify them that she is pregnant and was likely pregnant at the time of the procedure. The patient was estimated at 3-4 weeks pregnant at the time of this procedure. The dose received is assumed to be greater than the reporting limits provided in 10 CFR 35.3047 but is going to be provided in writing as licensee staff are continuing to validate dose calculations.

"According to the RSO, everything was administered in accordance [with] standard hospital procedures, and notifications have been made to the authorized user, referring physicians, and the obstetrician/gynecologist for the patient. It was discussed that adverse impact to the patient or the embryo is not expected from this procedure, as the fetal thyroid gland commences development around the fourth week of pregnancy and hormonal development commences around as early as week 10. Physician opinion at this time indicates that the greatest risks to the embryo development mostly derive from the existing patient's condition (hyperthyroidism) and not necessarily the treatment in question.

"The licensee is going to be submitting a written notification within fifteen (15) days in accordance with 10 CFR 35.3047(d), and providing a copy of this report to the referring physician in accordance with 10 CFR 35.3047(f).

"This incident is being tracked under incident number 1571. NYSDOH is monitoring this event and will provide updates to the U.S. NRC as soon as available."

NY event report ID: NY-26-05
NY incident number: 1571